Creation and assessment of a predictive model for recurrence in postoperative patients with stage ⅠA1-ⅢA non-small cell lung carcinoma - Top-Institutions - MDSpire

Creation and assessment of a predictive model for recurrence in postoperative patients with stage ⅠA1-ⅢA non-small cell lung carcinoma

By
Yi Li
Renjie Xu
Jinghong Xian
Zhoufeng Wang
Wang Chen
Weimin Li
November 27, 2025
0 min

Bmc Cancer

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Thoracic Oncology
- Surgical Oncology
- Molecular Pathology
- Radiology
#2

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Thoracic Surgery
- Medical Oncology
- Radiology
- Genomic Medicine
#3

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Thoracic Oncology
- Genomic Medicine
- Radiology
- Biostatistics
#4

National Cancer Center/National Clinical Research Center for Cancer

Beijing, China
Key Differentiators
- Thoracic Surgery
- Medical Oncology
- Molecular Diagnostics
- Radiology
#5

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Thoracic Surgery
- Oncology
- Radiology
- Genomics

Original Source(s)

Bmc Cancer

Creation and assessment of a predictive model for recurrence in postoperative patients with stage ⅠA1-ⅢA non-small cell lung carcinoma

by Yi Li, Renjie Xu, Jinghong Xian, Zhoufeng Wang, Wang Chen, Weimin Li
November 27, 2025

Related Content

Frontiers In Oncology

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Jama Network Open

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Frontiers In Oncology

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer